Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q4 2025 Earnings Call Transcript March 19, 2026 Taysha Gene Therapies, Inc. beats earnings expectations. Reported EPS is $-0.08711, expectations were ...

Neo Performance Materials Inc. ("Neo" or the "Company") (TSX: NEO) (OTCQX: NOPMF) today announced its financial results for the fourth quarter and full year 2025. Neo's financial statements and ...

Financial stability risks remain elevated amid stretched asset valuations, sovereign bond market pressures, and rising influence of nonbank financial institutions. Structural changes in foreign ...

SEC Chair Paul Atkins said the new securities guidance, which impacts "most crypto assets," provides "clear lines in clear terms." ...

Every informed financial investment decision is based on financial data. Most investors receive their financial data in PDF statements that are not suitable for analysis.

Precision-engineered platform combines GAAP-compliant accounting, 190 AI tools, and database-level controls to deliver ...

Abstract: Approximating macroeconomic indicators is challenging due to the complex interaction of various factors, including global and national economic trends, political decisions, and unpredictable ...

Truist Financial Corporation remains fundamentally sound, but valuation appears fully priced. Click here to read more on TFC stock.

Many organisations within the health service are grappling with a "perilous" financial situation, as analysis reveals NHS trusts collectively ran a deficit exceeding three-quarters of a billion pounds ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

Abstract: Artificial intelligence (AI)-based models have emerged as powerful tools in financial markets, capable of reducing investment risks and aiding in selecting highly profitable stocks by ...